After trial, University of Iowa lead researcher says therapeutic prostate cancer vaccine is safe

From HealthDay News via Washington Post:

A therapeutic vaccine to treat prostate cancer appears safe and may be effective, according to the results of an early trial.The vaccine could give hope to men with metastatic prostate cancer by activating their immune systems to fight the disease. The vaccine was developed to enable a patient's immune system to produce anti-antigens and attack cancer cells, which can improve quality of life and extend survival."The primary objective of the study was to determine whether or not the vaccine was safe or whether it induced any serious adverse events," said lead researcher

The vaccine could give hope to men with metastatic prostate cancer by activating their immune systems to fight the disease. The vaccine was developed to enable a patient's immune system to produce anti-antigens and attack cancer cells, which can improve quality of life and extend survival.

"The primary objective of the study was to determine whether or not the vaccine was safe or whether it induced any serious adverse events," said lead researcher Dr. David Lubaroff, director of urology research at the University of Iowa. "The vaccine was quite safe." ...

Lubaroff Lab Home Page

University of Iowa faculty page for David Lubaroff

[naviga:ul class="zemanta-article-ul" style="margin:1em 0 1.5em;padding:0"] [naviga:li class="zemanta-article"] [naviga:li class="zemanta-article"]

Related articles

[naviga:ul class="zemanta-article-ul" style="margin:1em 0 1.5em;padding:0"]

[naviga:li class="zemanta-article"]'Matilda the robot' performs prostate operation [via Zemanta]

[naviga:li class="zemanta-article"]A Review of Prostate Cancer Leaves Men in a Muddle [via Zemanta]